Myriad Genetics, Inc. (MYGN) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Myriad Genetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.197 Good day and thank you for standing by. Welcome to the Myriad Genetics Third Quarter 00:00:04.197 -- 00:00:09.605 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. 00:00:09.605 -- 00:00:13.150 After the speaker's presentation, there will be a question and answer session. 00:00:13.150 -- 00:00:16.835 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:16.835 -- 00:00:20.660 You will then hear an automated message advising that your hand is raised. 00:00:20.660 -- 00:00:23.865 To withdraw your question, please press star 1-1 again. 00:00:23.865 -- 00:00:26.828 Please be advised that today's conference is being recorded. 00:00:26.828 -- 00:00:30.276 I would now like to hand the conference over to your first speaker today, Matt Skylow. 00:00:30.276 -- 00:00:32.757 Please go ahead. 00:00:33.664 -- 00:00:38.795 Good afternoon, and welcome to the MIRI Genetics third quarter 2025 earnings 00:00:38.795 -- 00:00:43.586 call. During the call, we will review the financial results we released today, and afterwards, 00:00:43.586 -- 00:00:48.720 we will host a Q&A session. Our quarterly earnings release was issued this afternoon 00:00:48.720 -- 00:00:53.785 on Form 8K and can be found on our website at investor.myriad.com. 00:00:54.389 -- 00:00:57.874 I'm Matt Scalise, Senior Vice President of Investor Relations. 00:00:57.874 -- 00:01:02.942 On the call with me today are Sam Raha, our President and Chief Executive Officer, Ben 00:01:02.942 -- 00:01:08.172 Wheeler, our Chief Financial Officer, and Mark Verratti, our Chief Operating Officer. 00:01:08.172 -- 00:01:12.982 This call can be heard live via webcast at investor.myriad.com 00:01:13.270 -- 00:01:18.187 and a r...